<DOC>
	<DOC>NCT02804919</DOC>
	<brief_summary>Phase 1:The study is to evaluate the product reliability, therapy effectiveness and user feedback of a Continuous Positive Airway Pressure (CPAP) device in-home for up to 6 months. Phase 2: To evaluate the CPAP device with communication functionality with data upload.</brief_summary>
	<brief_title>CPAP In-home Assessment NZ</brief_title>
	<detailed_description>Phase 1:Existing and Na√Øve CPAP users will be recruited into a 6 month in-home study Participants will attend 5 study visits at day 0, 7, 30, 60 and 180. Outcome of the clinical investigation include downloadable device data reports, device error reports and participants perception questionnaires. Phase 2: 10 participants from Phase 1 will be recruited to use the device for up to 6 month in-home. Participants will attend 3 study visits at day 0, 7 30. The trial may be extended to 60 days if longer term data is required.</detailed_description>
	<mesh_term>Sleep Apnea, Obstructive</mesh_term>
	<criteria>Aged 18 and over Diagnosed with Obstructive Sleep Apnea (OSA) and prescribed Positive Airway Pressure (either Continuous positive airway pressure (CPAP) or AutoCPAP) Be fluent in spoken and written English Contraindicated for Positive Airway Pressure (CPAP or AutoCPAP) therapy Persons with other significant sleep disorder(s) (e.g periodic leg movements, insomnia, central sleep apnea) Persons with obesity hypoventilation syndrome or congestive heart failure Persons that require supplemental oxygen with their Positive Airway Pressure (CPAP or AutoCPAP) device. Persons with implanted electronic medical devices (e.g cardiac pacemakers) Persons who are pregnant or think they may be pregnant.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>